Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
Division of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
Aging Cell. 2024 Jun;23(6):e14144. doi: 10.1111/acel.14144. Epub 2024 Mar 18.
Aging coincides with the progressive loss of muscle mass and strength, increased adiposity, and diminished physical function. Accordingly, interventions aimed at improving muscle, metabolic, and/or physical health are of interest to mitigate the adverse effects of aging. In this study, we tested a stem cell secretome product, which contains extracellular vesicles and growth, cytoskeletal remodeling, and immunomodulatory factors. We examined the effects of 4 weeks of 2×/week unilateral intramuscular secretome injections (quadriceps) in ambulatory aged male C57BL/6 mice (22-24 months) compared to saline-injected aged-matched controls. Secretome delivery substantially increased whole-body lean mass and decreased fat mass, corresponding to higher myofiber cross-sectional area and smaller adipocyte size, respectively. Secretome-treated mice also had greater whole-body physical function (grip strength and rotarod performance) and had higher energy expenditure and physical activity levels compared to control mice. Furthermore, secretome-treated mice had greater skeletal muscle Pax7+ cell abundance, capillary density, collagen IV turnover, reduced intramuscular lipids, and greater Akt and hormone sensitive lipase phosphorylation in adipose tissue. Finally, secretome treatment in vitro directly enhanced muscle cell growth and IL-6 production, and in adipocytes, it reduced lipid content and improved insulin sensitivity. Moreover, indirect treatment with secretome-treated myotube culture media also enhanced muscle cell growth and adipocyte size reduction. Together, these data suggest that intramuscular treatment with a stem cell secretome improves whole-body metabolism, physical function, and remodels skeletal muscle and adipose tissue in aged mice.
衰老是伴随着肌肉质量和力量的逐渐丧失、脂肪量增加和身体功能下降而发生的。因此,旨在改善肌肉、代谢和/或身体健康的干预措施对于减轻衰老的不利影响是有意义的。在这项研究中,我们测试了一种干细胞分泌产物,它含有细胞外囊泡以及生长、细胞骨架重塑和免疫调节因子。我们研究了 4 周 2×/周单侧肌肉内分泌产物注射(股四头肌)对有活动能力的老年雄性 C57BL/6 小鼠(22-24 个月)的影响,并与接受生理盐水注射的老年匹配对照组进行了比较。分泌产物的传递大大增加了全身瘦体重,减少了脂肪量,分别对应于更高的肌纤维横截面积和更小的脂肪细胞大小。与对照组相比,接受分泌产物治疗的小鼠也具有更高的全身身体功能(握力和转棒性能),以及更高的能量消耗和身体活动水平。此外,与对照组相比,接受分泌产物治疗的小鼠的骨骼肌 Pax7+细胞丰度更高,毛细血管密度更高,胶原蛋白 IV 周转率更高,肌肉内脂质减少,脂肪组织中的 Akt 和激素敏感脂肪酶磷酸化增加。最后,分泌产物在体外直接增强肌肉细胞的生长和 IL-6 的产生,在脂肪细胞中,它减少了脂质含量并改善了胰岛素敏感性。此外,间接用分泌产物处理的肌管培养物培养基也增强了肌肉细胞的生长和减少了脂肪细胞的大小。综上所述,肌肉内注射干细胞分泌产物可改善老年小鼠的全身代谢、身体功能,并重塑其骨骼肌和脂肪组织。